Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03545893 · ClinicalTrials.gov registry record · Phase 4
Overnight Pain Treatment Investigating Opioids vs. Nonopioids
A Phase 4 study of Abortion, Second Trimester, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT03545893: Completed Phase 4 study of Abortion, Second Trimester, sponsored by University of Pennsylvania.
NCT03545893 is a Phase 4 study of Abortion, Second Trimester that has completed, run by University of Pennsylvania. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03545893, a Phase 4 study of Abortion, Second Trimester, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare maximum pain scores between patients seeking induced abortion and requiring cervical preparation with osmotic dilators. Patients will be randomized to receive prescription for ibuprofen alone or to receive prescription for ibuprofen + oxycodone for overnight pain management after cervical preparation with osmotic dilators. Data collected in-person and through a text-messaging platform.
Primary Outcome
Numerical Rating Scale (NRS) pain score (scale range 0-10, with a 0 meaning "no pain" and 10 meaning the "worst possible pain")
Conditions Studied
Interventions
- DRUG Ibuprofen 600 mg
- DRUG OxyCODONE 5 Mg Oral Tablet
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-06-19 |
| Est. Completion | 2019-02-07 |
| Phase | Phase 4 |
What the finished NCT03545893 record still lists
NCT03545893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Abortion, Second Trimester appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen 600 mg is the first listed.
NCT03545893 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03545893 about?
NCT03545893 is a clinical study titled "Overnight Pain Treatment Investigating Opioids vs. Nonopioids". The purpose of this study is to compare maximum pain scores between patients seeking induced abortion and requiring cervical preparation with osmotic dilators. Patients will be randomized to receive prescription for ibuprofen alone or to receive prescription for ibuprofen + oxycodone for overnight p...
What is the current status of trial NCT03545893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2018-06-19. Estimated completion is 2019-02-07.
What conditions does trial NCT03545893 study?
This clinical trial studies the following conditions: Abortion, Second Trimester.
What interventions are being tested in trial NCT03545893?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), OxyCODONE 5 Mg Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT03545893?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03545893 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abortion, Second Trimester
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03545893's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI